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Adipose tissue hypoxia and inflammation have been
causally implicated in obesity-induced insulin resis-
tance. Here, we report that, early in the course of
high-fat diet (HFD) feeding and obesity, adipocyte
respiration becomes uncoupled, leading to in-
creased oxygen consumption and a state of relative
adipocyte hypoxia. These events are sufficient to
trigger HIF-1a induction, setting off the chronic adi-
pose tissue inflammatory response characteristic of
obesity. At the molecular level, these events involve
saturated fatty acid stimulation of the adenine nucle-
otide translocase 2 (ANT2), an inner mitochondrial
membrane protein, which leads to the uncoupled
respiratory state. Genetic or pharmacologic inhibi-
tion of either ANT2 or HIF-1a can prevent or reverse
these pathophysiologic events, restoring a state of
insulin sensitivity and glucose tolerance. These
results reveal the sequential series of events in
obesity-induced inflammation and insulin resistance.INTRODUCTION
Obesity is characterized by low-grade chronic inflammation in
adipose tissue, liver, and skeletal muscle (Glass and Olefsky,
2012; Shu et al., 2012). This inflammatory state progresses dur-
ing the course of obesity and can lead to systemic insulin resis-
tance, hyperinsulinemia, and glucose intolerance (Lee et al.,
2011b). In obesity, adipocyte hypertrophy—combined with
compromised adipose tissue vascularization—restricts oxygen
availability, leading to areas of adipose tissue hypoxia (Pasaricaet al., 2009), and recent evidence suggests that this can cause
adipose tissue dysfunction in obesity (Hosogai et al., 2007).
The hypoxia response is largely mediated by hypoxia-inducible
factors (HIFs). HIFs are heterodimeric basic helix-loop-helix
transcription factors composed of two dimeric subunits: an
oxygen-sensitive a subunit and a ubiquitously and constitutively
expressed b subunit, HIF-1b (ARNT) (Keith et al., 2012). There are
two major a subunits, HIF-1a and HIF-2a, which are differentially
regulated by oxygen tension and metabolic signals (Keith et al.,
2012). Under normal conditions, a subunits are hydroxylated by
prolyl hydroxylases (PHDs), which allows the ubiquitin ligase Von
Hippel-Lindau tumor suppressor (VHL) to ubiquitinate HIF-1a,
which is then targeted for proteolytic degradation via the protea-
somal pathway. The hydroxylation step is inhibited under
hypoxic conditions, leading to stabilization and increased
expression of HIF-1a. HIF-1a and HIF-2a regulate different sub-
sets of genes, although they can share common targets such as
VEGF and GLUT1 (Keith et al., 2012). In arginine homeostasis,
HIF-1a induces iNOS expression and increases nitric oxide
(NO) production from arginine, whereas HIF-2a stimulates argi-
nase expression, and suppresses NO production (Branco-Price
et al., 2012; Melillo et al., 1996; Takeda et al., 2010). Therefore,
identification of differential roles of adipocyte HIF-1a and HIF-
2a is essential to understand the molecular mechanisms of the
metabolic consequences of adipose tissue hypoxia in obesity.
Recently, it has been reported that adipocyte-specific
HIF-1a-overexpressing mice develop insulin resistance with
increased adipose tissue inflammation due to induction of the
fibrotic program (Halberg et al., 2009). Deletion of either HIF-1b
or HIF-1a in adipocytes protects mice from high-fat diet (HFD)-
induced insulin resistance (Jiang et al., 2011; Krishnan et al.,
2012; Lee et al., 2011a). Deletion of HIF-1b results in the loss
of transcriptional activity of both HIF-a factors and other factors
that bind HIF-1b, such as the Aryl hydrocarbon receptor (AhR)Cell 157, 1339–1352, June 5, 2014 ª2014 Elsevier Inc. 1339
Figure 1. Increased Adipocyte Oxygen Consumption by FFA-Induced Uncoupled Respiration Contributes to Adipose Tissue Hypoxia in
Obesity
(A) Whole-mount immunohistochemistry analysis of eWAT from mice fed NCD or HFD for 3 days. Green, pimonidazole adduct; red, perilipin; blue, PECAM-1.
(B) Western blot analysis of HIF-1a in eWAT.
(C and D) qPCR analysis of VEGF expression (C) or lactate concentration (D) in eWAT frommice fed NCD or HFD. D1, 1 day HFD; D3, 3 day HFD; D7, 7 day HFD;
W10, 10 week HFD. n = 8 per group.
(E) Relative oxygen consumption rate in the presence or absence of oligomycin in primary adipocytes from NCD/lean or HFD/obese mice. n = 4 per group.
(F) FFA level in eWAT of NCD or HFD mice. n = 5–7 per group. *p < 0.05; **p < 0.01.
(G) Oxygen consumption rate in 3T3-L1 adipocytes before and after BSA, KLA (Kdo2), or each of FFAs indicated (50 mM) in the presence or absence of an inhibitor
of ANT, CAtr. *p < 0.05; **p < 0.01.
(H) Palmitate-induced respiration is not inhibited by Etomoxir (Etom) or oligomycin (Oligo).
(I) ATP production as calculated from Seahorse data as described previously (Sridharan et al., 2008).
(J) Palmitate induces hypoxia (pimonidazole adducts) in cultured 3T3-L1 adipocytes. Detailed protocols are described in the Extended Experimental Procedures.
Blue, DAPI; green, hypoxia probe.
(K) Western blot analysis of HIF-1a protein in 3T3-L1 adipocytes with or without palmitate (100 mM) and/or CAtr (1 mM).
(L) Acute injection of CAtr reduces adipocyte hypoxia in mice fed a HFD for 3 days. Green, hypoxia probe; red, BODIPY.
All data are mean ± SEM. See also Figure S1.with which HIF-1b also dimerizes. Loss of HIF-1a alone may
cause phenotypic effects chiefly related to the remaining activity
of HIF-2a. Thus, the effect of HIF-1a versus HIF-2a needs
to be established to understand their roles in adipocyte
metabolism and obesity. To assess these issues, we generated
HIF-1a adipocyte knockout (KO) (HAKO), HIF-2a adipocyte KO
(H2AKO), and HIF-1a and HIF-2a double-adipocyte KO
(DHAKO) mice and analyzed their metabolic phenotypes and
underlying mechanisms. We found that obesity leads to adenine
nucleotide translocase (ANT)-mediated uncoupled respiration,
increased adipocyte oxygen consumption, and a state of relative
hypoxia, triggering induction of HIF-1a. Adipocyte HIF-1a
deletion results in decreased inflammation and insulin resis-
tance, whereas HIF-2a ablation causes increased inflammation
and insulin resistance.1340 Cell 157, 1339–1352, June 5, 2014 ª2014 Elsevier Inc.RESULTS
Adipocyte Oxygen Consumption Increases on HFD
Recently, it has been shown that oxygen tension decreases in
adipose tissue of obese subjects and obese animal models
(Halberg et al., 2009; Pasarica et al., 2009). Consistent with
this, we observed that adipocyte hypoxia is induced as early
as 1 and 3 days of HFD, as measured by staining of hypoxia
adducts with pimonidazole (Figures 1A and S1A available on-
line). Moreover, HIF-1a protein levels, VEGF messenger RNA
(mRNA) (a well-known HIF-1a target gene) expression, and
lactate accumulation (a hypoxic respiration product) were also
markedly increased by 3 days of HFD (Figures 1B–1D and
S1B). Hypoxia is induced by an imbalance between oxygen sup-
ply and consumption, and the hypoxia literature shows that
increased tissue oxygen consumption (Doege et al., 2005;
Hagen et al., 2003; Sato et al., 2011) can be a major cause of
relative tissue hypoxia. To test this, we isolated primary adipo-
cytes from lean and HFD/obese mice and found that the oxygen
consumption ratewas significantly increased byHFD (Figure 1E).
This effect was observed in adipocytes isolated from both short-
term (3 days) and chronic (30 weeks) HFD-fed mice. Interest-
ingly, this increase was not abrogated by oligomycin treatment,
suggesting an increase in uncoupled respiration. Therefore, it
seems reasonable to conclude that an important mechanism
for relative adipocyte hypoxia with HFD and obesity is related
to increased uncoupled utilization of oxygen.
Adipose tissue is exposed to high circulating free fatty acid
(FFA) levels in obesity (Figure S1C), and to directly assess
adipocyte FFA exposure, we measured total FFA levels within
the epididymal adipose fat pads. This lipid fraction is distinct
from triacylglycerols and diacylglycerols (Figure S1D), and as
Figure 1F shows, adipose tissue FFA levels were elevated at
3 days, 7 days, and 15 weeks of HFD. To test whether FFAs
can increase oxygen consumption, we incubated 3T3-L1 adipo-
cytes with different FFAs such as myristrate, laurate, and palmi-
tate. As seen in Figure 1G, the oxygen consumption rate was
significantly increased by the different saturated FAs (SFAs).
Interestingly, oxygen consumption was not increased by the
TLR4-specific ligand Kdo2-Lipid A (KLA) (Sims et al., 2010),
showing that the FFA-mediated increase in adipocyte oxygen
consumption was not due to TLR4 activation (Figure 1G).
SFAs Increase O2 Consumption by Stimulating ANT2
ANT1 and 2 are mitochondrial inner-membrane proteins that
pump protons out of the intermembrane space into the mito-
chondrial matrix (Andreyev et al., 1988). Thus, excessive ANT
activity will cause proton leakage from the intermembrane
space, leading to uncoupled respiration (Brand et al., 2005). In
theory, SFAs can increase oxygen consumption by increasing
FA oxidation or by activating the ANT-dependent uncoupling of
oxidative metabolism. To assess these possibilities, we treated
adipocytes with palmitate in the presence or absence of inhibi-
tors of carnitine palmitoyl transferase-1 or ANT. As seen in Fig-
ure 1G, the FFA-dependent increase in oxygen consumption
was suppressed by the ANT inhibitor carboxyatractyloside
(CAtr), whereas inhibition of carnitine-palmitoyl transferase with
etomoxir or treatment with oligomycin did not attenuate the
FFA effect (Figure 1H). Consistent with this, ATP production
was not increased by palmitate treatment (Figure 1I), further
showing that the FFA-induced increase in oxygen consumption
was due to ANT-mediated uncoupling of oxidative metabolism
rather than increased FA oxidation.
Incubation of 3T3-L1 adipocytes with palmitate increased HIF-
1a protein expression and mRNA levels of HIF-1a target genes,
as well as the number of cells staining positive for pimonidazole
adducts (Figures 1J, 1K, and S1E). Both of these effects were
blunted by cotreatment with CAtr (Figure 1K). Furthermore,
acute in vivo treatment of mice with CAtr reduced the number
of hypoxic adipocytes in epididymal white adipose tissue
(eWAT) in 3 day HFD mice (Figure 1L). These results support
the view that HFD causes an increase in adipocyte oxygen con-
sumption due to ANT-mediated uncoupled respiratory meta-bolism (Figure 1E), leading to a state of relative adipocyte hypox-
ia and induction of the HIF-1a transcriptional program.
ANT Inhibition Ameliorates Adipose Tissue Hypoxia,
Inflammation, and Insulin Resistance in HFD/Obese
Mice
In mice, three isoforms of ANT have been identified: ANT1,
ANT2, and ANT4 (Zhivotovsky et al., 2009). As seen in Figure 2A,
ANT1, ANT2, and UCP2 are abundantly expressed in white
adipocytes, whereas expression of ANT4, UCP1, and UCP3 is
negligible. HFD slightly decreased ANT1 expression (Figure 2A),
whereas ANT2 was reduced by 25% at 15 weeks of HFD (Fig-
ure 2A).UCP2was decreased by 43%byHFD (Figure 2A). These
results suggest that, unlike brown adipocytes, which are more
UCP1/3-dependent (Figure S2), uncoupled respiration in HFD
white adipocytes is largely mediated by ANTs.
To determine the relative contribution of ANT1 and ANT2 to
SFA-induced adipocyte uncoupled respiration, we used RNAi
to knockdown (KD) ANT1, ANT2, or both, in 3T3-L1 adipo-
cytes. These studies revealed a reciprocal relationship be-
tween ANT1 and ANT2, such that, when ANT1 was depleted,
ANT2 expression increased, whereas KD of ANT2 caused an
increase in ANT1. This was fortuitous, allowing us to dissect
the roles of these two isoforms in basal versus FA-stimulated
respiration. When ANT1 was depleted, the basal respiration
rate was substantially diminished, but the effect of palmitate
was still present, although moderate (Figure 2B). With ANT2
KD, basal respiration went up (because ANT1 was increased
with the ANT2 KD), whereas the effect of palmitate to stimulate
respiratory rates was completely ablated (Figure 2B). KD of
both ANT1 and ANT2 decreased the basal respiration rate
and abrogated the effect of palmitate. These data indicate
that ANT1 is mostly responsible for the basal rate of mitochon-
drial respiration and that ANT2 is the major target of fatty acid
stimulation. To extend this KD approach to the in vivo situation,
we generated an adenovirus-associated viral (AAV) vector ex-
pressing anti-ANT2 small hairpin RNA (shRNA) and injected
this or a control antiluciferase shRNA AAV vector into epidid-
ymal fat pads of wild-type (WT) mice. Three weeks after injec-
tion, the mice were placed on HFD. After 3 days of HFD, ANT2
was depleted by 80%, and pimonidazole adduct staining was
decreased by 60% (Figure 2C). Collectively, these data indi-
cate that activation of ANT2 causes the palmitate-induced
increase in uncoupled respiration and the state of relative
adipocyte hypoxia.
To test whether inhibition of ANT activity and adipocyte hypox-
ia can protect HFD/obese mice from adipose tissue inflamma-
tion and glucose intolerance, we treated 10 week HFD mice
with lower doses of CAtr (0.4 and 1.0 mg/kg) for 9 days. As
seen in Figure 2D, 0.4 mg/kg and 1.0 mg/kg of CAtr reduced
the number of hypoxic adipocytes and adipose tissue macro-
phages (ATMs) without change in body weight or blood oxygen
saturation (Figures 2E and 2F). Interestingly, adipose tissue
mass was significantly increased by CAtr treatment (Figure 2G).
CAtr treatment improved glucose and insulin tolerance and
reduced hyperinsulinemia in HFD mice (Figures 2H and 2I), indi-
cating that chronic inhibition of the ANT-dependent increase in
uncoupled adipocyte respiration ameliorates adipocyte hypoxia,Cell 157, 1339–1352, June 5, 2014 ª2014 Elsevier Inc. 1341
Figure 2. Effects of ANT Inhibition in Obesity
(A) Expression of different isoforms of ANT and UCP genes in isolated primary eWAT adipocytes of chow or HFDmice at 1 day (left) or 15 weeks (right). *p < 0.05;
**p < 0.01.
(B) Effect of ANT1 or ANT2 KD in 3T3-L1 adipocytes. 3T3-L1 adipocytes were transfected with scrambled siRNA (Sc) or siRNAs against ANT1(A1), ANT2 (A2), or
both (A1+2), and oxygen consumption rate was measured using Clark type electrode. *p < 0.05.
(C) In vivo ANT2 KD decreases adipose tissue hypoxia. Green staining (middle) represents pimonidazole adduct-positive area. *p < 0.05; **p < 0.01.
(D–I) Effect of chronic CAtr treatment on hypoxia (D), body weight (E), blood oxygenation (F), eWAT and liver weight (G), glucose tolerance (H), and insulin
tolerance (I) at days 5–9. The graph shows body weight at day 5. *p < 0.05; **p < 0.01;x, p < 0.05 0.4 mg/kg CAtr versus control; ; #, p < 0.05 1.0mg/kg CAtr versus
control.
All data are mean ± SEM. See also Figure S2.adipose tissue inflammation, glucose intolerance, and insulin
resistance in chronic HFD/obese mice.
Adipocyte HIF-1a KO Facilitates Fat Mobilization from
Liver to Adipose Tissue
Wenext studied the effect of adipocyteHIF-1adeletion by gener-
ating HIF-1a adipocyte KO (HAKO) mice (Figures S3A and S3B).
HIF-1a deletion was restricted to adipocytes, with no deletion
detected in stromal vascular cells (SVCs), muscle, liver, or intra-
peritoneal (IP) macrophages (Figure S3A). As expected, HIF-1a
was quantitatively deleted in interscapular brown adipose tissue
(BAT) (Figure S3A), as well as WAT. UCP1-3 expression in BAT
was the same in WT versus HAKO mice (Figure S2). The HAKO1342 Cell 157, 1339–1352, June 5, 2014 ª2014 Elsevier Inc.mice exhibited normal body weight on either chow or HFD with
no differences in food intake compared to WT controls (Fig-
ure S3C). In obesity, hypoxia can induce adipose tissue fibrosis,
restricting adipocyte expansion and lipid storage (Halberg et al.,
2009). In HAKO mice, adipose tissue fibrosis was markedly
reduced on HFD as measured by trichrome staining (Figure S3D)
with a concomitant increase in adipose tissue mass and mean
adipocyte size (Figures S3E–S3H). Oxygen consumption rate in
HAKO eWAT adipocytes was comparable to WT adipocytes on
normal chowdiet (NCD)butwashigher onHFD (FigureS3I),which
is consistent with the view that one function of the HIF-1a
response is to decrease oxygen consumption in an attempt to
mitigate hypoxia. Adipose tissue vascular density as measured
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Figure 3. HIF-1a KO Mice Exhibit Improved Glucose Tolerance and Insulin Sensitivity on HFD
(A) GTT with mice fed NCD.
(B) GTT with mice fed HFD for 10 weeks.
(C) Plasma insulin level during GTT in (B).
(D) ITT in mice fed HFD for 11 weeks.
(E) Hyperinsulinemic euglycemic clamp performed on mice fed a HFD for 15 weeks.
(F) Glucose uptake assays using primary adipocytes from WT or HAKO mice fed HFD for 15 weeks.
All data represent mean ± SEM. See also Figure S3.by CD31-positive staining of eWAT was not changed in HAKO
mice (Figure S3J). Hepatic triglyceride (TG) content was signifi-
cantly decreased in HAKO mice (Figures S3K and S3L), indi-
cating a redistribution of lipid stores from liver to adipocytes on
HFD. Interestingly, expression of inflammatory genes such as
TNFa and IL-1b, as well as the lipogenic gene fatty acid synthase,
was decreased in the liver of HAKO mice (Figure S3M).
AdipocyteHIF-1aKOProtects fromHFD-Induced Insulin
Resistance
Glucose tolerance was comparable between WT and HAKO
mice onNCD,whereas, the KOmice exhibited improved glucose
tolerance with reduced plasma insulin levels on HFD (Figures
3A–3C). These findings suggested protection fromHFD-induced
insulin resistance, and this concept was confirmed with insulin
tolerance tests (ITTs), which showed a greater glucose lowering
effect of insulin in the HAKO compared to WT mice (Figure 3D).
To quantitate overall insulin sensitivity and to determine tissue-
specific contributions, hyperinsulinemic-euglycemic clamp
studies were performed. As seen in Figure 3E, the glucose infu-
sion rate (GIR) required tomaintain euglycemia was substantially
higher in HFD-fed HAKO mice compared to WT. Furthermore,
insulin-stimulated glucose disposal rate (IS-GDR), insulin sup-
pression of hepatic glucose production (HGP), and suppression
of circulating FFA levels were all markedly increased in HAKO
mice, demonstrating that adipocyte HIF-1a deletion leads to
systemic insulin sensitivity in muscle, liver, and adipose tissueon HFD. Consistent with these results, ex vivo studies in primary
isolated adipocytes demonstrated improved stimulation of
glucose transport in KO compared with WT adipocytes from
HFD mice (Figure 3F).
Adipocyte HIF-1a KO Protects from HFD-Induced
Adipose Tissue Inflammation
To test the potential role of HIF-1a in adipose tissue inflammation
in the context of obesity, we analyzed ATMs in WT and HAKO
mice on NCD or HFD. Immunohistochemistry revealed
decreased ATMs in HAKO mice on HFD compared to WT (Fig-
ure 4A). Next, we performed flow cytometry studies on SVCs
from WT and HAKO adipose tissue on a NCD or HFD. As seen
in Figure 4B, the ratio of CD11b and F4/80 double-positive
ATMs or M1-like polarized CD11b, F4/80, and CD11c triple-
positive ATMs was markedly decreased in adipose tissue from
HFD HAKO mice. Consistent with these results, mRNA expres-
sion of macrophage marker genes such as F4/80 and CD11b
and inflammatory genes such as TNFa, IL-6, Rantes, MIP-1a,
MCP-1, and CYR61 was reduced in HAKO adipose tissue (Fig-
ure 4C). Moreover, expression of major histocompatibility com-
plex (MHC) class II genes such as H2-Aa and CD74, which are
increased in obese human adipocytes (Deng et al., 2013), was
also reduced in primary adipocytes of HAKO mice (Figure 4D).
Lastly, plasma levels of MCP-1 and resistin were reduced,
whereas circulating adiponectin was increased in HAKO mice
(Figure 4E).Cell 157, 1339–1352, June 5, 2014 ª2014 Elsevier Inc. 1343
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Figure 4. HAKO Mice Exhibit Reduced Macrophage Infiltration and Inflammatory Gene Expression with Reduced Chemokine and LTB4
Production
(A) IHC analysis of ATMs from WT or HAKO mice fed a HFD for 15 weeks. Red, neutral lipids (BODIPY); green, macrophage (CD11b). n = 5 or 6 per group.
(B) Flow cytometry analysis of eWAT SVCs from 15 week HFD mice. n = 4 (NCD) or 7 (HFD) per group.
(C) mRNA levels of inflammatory genes in adipose tissue were measured by RT-PCR analysis. n = 6.
(D) mRNA levels of class II MHC genes in primary adipocytes were measured by RT-PCR. n = 7 per group.
(E) Plasma levels of adipokines (n = 7) as measured by ELISA or western blots.
(F) Chemoattractive activity of ACM harvested from HAKO adipocytes is reduced compared with WT adipocytes (15 week HFD). n = 4 per group.
(G) FLAP mRNA level in adipocyte and SVC fractions of eWAT from mice fed NCD or HFD (15 weeks). n = 7 or 9 per group.
(H) LTB4 release from isolated adipocytes of NCD WT, HFD WT, or HFD HAKO mice. n = 3 or 7 per group.
(I) In vivo monocyte tracking (n = 4).
All data represent mean ± SEM. See also Figure S4.In macrophages and endothelial cells, HIF-1a can lead to the
induction of chemoattractive factors such as MCP-1 and Leuko-
triene B4 (LTB4) (Gonsalves and Kalra, 2010; Spite et al., 2011).
Thus, we measured adipocyte-conditioned media (ACM)-
induced chemotaxis in Transwell dishes. As seen in Figure 4F,
migration of Raw264.7 macrophages to HAKO ACM was
decreased compared with WT ACM. Moreover, mRNA level of
5-lipoxygenase-activating protein (FLAP), the enzyme producing
LTB4, and production of LTB4 from primary HAKO adipocytes
were decreased in HAKO adipose tissue (Figures 4G and 4H).
To directly assess the mechanistic links between hypoxia, HIF-
1a, and chemokine release, we conducted in vitro studies in
3T3-L1 adipocytes. These experiments showed that, under1344 Cell 157, 1339–1352, June 5, 2014 ª2014 Elsevier Inc.hypoxic conditions, expression of a wide array of proinflam-
matory adipocyte genes was increased, including FLAP and
MCP-1 (Figures S4A and S4B), whereas the hypoxia-dependent
increase inMCP-1, FLAP, and iNOS expression was reduced by
HIF-1a knockdown (Figure S4B). Chromatin immunoprecipita-
tion sequence analysis revealed that HIF-1a binds to the FLAP
and p65 (NF-kB) gene promoters under hypoxic conditions (Fig-
ure S4C). A heat map also shows occupancy of other inflam-
matory pathway genes and hypoxia target genes by HIF-1a.
Furthermore, ACM harvested from hypoxic 3T3-L1 adipocytes
elicited greater macrophage chemotaxis than normoxic ACM,
and the hypoxia-dependent increase was reduced in HIF-1a
KD adipocytes (Figure S4D).
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Figure 5. HAKO Mice Fed a HFD Show Reduced NO Production and Akt Nitrosylation and Lower Lactate Production in Adipocytes
(A) mRNA levels of iNOS and arginase 1 in adipocyte and eWAT SVCs from WT and HAKO mice. n = 4 or 7 per group.
(B) Nitrite level in eWAT of WT and HAKO mice. n = 4 or 5 per group.
(C) HFD-induced nitrosylation of Akt, and total protein in adipose tissue is reduced by HAKO.
(D) Akt phosphorylation in eWAT from WT or HAKO mice before and after insulin injection.
(E) PDK expression. n = 4 or 7 per group.
(F) Fasting HGP is lower in HAKO mice on HFD.
(G) Adipose tissue lactate content is decreased in HAKO mice. n = 5 per group.
All data represent mean ± SEM.To assess chemotaxis in vivo, we conducted macrophage-
tracking studies. With this approach, WT blood monocytes
were obtained from a donor mouse and labeled ex vivo with fluo-
rescent PKH26 dye. The fluorescently labeled monocytes were
then injected into HFD WT or HAKO recipient mice, and the
appearance of the labeled cells as ATMs was measured. As
seen in Figure 4I, a marked decrease in labeled ATM appearance
was observed in the HAKO mice compared with WT. Fluores-
cence-activated cell sorting (FACS) analysis showed that this
was due to a decrease in the proinflammatory F4/80, CD11b,
and CD11c triple-positive ATM population (Figure 4I, third set
of bars) with an increase in the noninflammatory CD11c()
ATMs (righthand bars). Taken together, these results indicate
that HIF-1a can play a key initiating role in adipose tissue ATMaccumulation and inflammation by stimulating chemokine and
LTB4 production in obesity.
HIF-1a Increases Production of NO and Lactate in
Adipocytes
Previously, it was shown that HIF-1a stimulates NO production
by inducing iNOS expression in macrophages (Takeda et al.,
2010). Interestingly, NO can attenuate insulin signaling through
nitrosylation of insulin-signaling molecules such as Akt, and
this suppresses Akt phosphorylation/activation (Yasukawa
et al., 2005). Thus, we measured mRNA levels of iNOS and
arginase 1 in primary adipocytes and SVCs in eWAT from WT
or HAKO mice. As shown in Figure 5A, iNOS expression was
induced in adipocytes and SVCs by HFD, and this effect wasCell 157, 1339–1352, June 5, 2014 ª2014 Elsevier Inc. 1345
blunted in cells from HAKO mice. HFD also led to increased
arginase 1 expression, and this increase was enhanced in
HAKO mice. Thus, the iNOS/arginase ratio was markedly
reduced in HAKO adipose tissue. As would be predicted from
these gene expression changes, levels of adipose tissue NO2,
a stable breakdown product of NO, were induced 3-fold on
HFD in WT mice, and this increase was almost completely abro-
gated in HAKO mice (Figure 5B). Consistent with these changes
in NO levels, nitrosylation of total protein, including Akt, was
increased on HFD and was reduced in HAKO adipose tissue
(Figure 5C). Concomitant with this, insulin-stimulated Akt phos-
phorylation was greater in adipose tissue from HFD HAKO
versus WT mice (Figure 5D).
Because adipose tissue is one of the major sources of
lactate production (DiGirolamo et al., 1992; Qvisth et al.,
2007), we hypothesized that HIF-1a increases lactate produc-
tion from hypoxic HFD adipocytes, contributing to increased
basal hepatic glucose production and higher fasting blood
glucose levels. In HFD WT adipose tissue, expression of
PDK1, 2, and 4 was increased, and these changes were blunt-
ed in adipose tissue from HFD HAKO mice (Figure 5E). Consis-
tent with this, HAKO mice exhibited lower basal HGP rates and
lactate content in adipose tissue on HFD (Figures 5F and 5G)
with reduced basal blood glucose levels (Figure 3B). These
data suggest that adipocyte hypoxia and HIF-1a activation
stimulate lactate production from adipocytes, which supports
increased hepatic glucose production and elevated basal
blood glucose levels.
HIF-2a KO Exacerbates HFD-Induced Inflammation and
Insulin Resistance
Recently, opposing roles of HIF-1a and HIF-2a have been sug-
gested in macrophages and in cancer progression (Keith et al.,
2012). In adipose tissue, HFD decreases HIF-2a protein levels,
whereas it induces HIF-1a expression (Jiang et al., 2011). To
examine the role of HIF-2a in adipose tissue, we generated
H2AKO and DHAKO mice (Figures 6A and S5A). H2AKO mice
exhibited normal body weight on NCD but were slightly heavier
on HFD without changes in eWAT mass (Figures 6B and 6C).
Whereas glucose tolerance was normal on NCD in H2AKO (Fig-
ure 6D), on HFD, H2AKO mice exhibited more severe glucose
intolerance and hyperinsulinemia compared with WT (Figures
6E and 6F), indicating a greater susceptibility to HFD-induced
insulin resistance. Confirming this formulation, ITTs showed an
impaired glucose-lowering effect of insulin in H2AKO mice (Fig-
ure 6G). Next, we measured adipose tissue inflammation using
flow cytometry analyses of SVCs. As seen in Figure 6H, the per-
centage of CD11b and F4/80 double-positive or M1-like CD11b,
F4/80, and CD11c triple-positive ATMs was increased in H2AKO
HFD adipose tissue. mRNA expression of inflammatory genes
such as FLAP, IL-6, and TNFa was also increased in HFD
H2AKO adipocytes and adipose tissue (Figures 6I and S5B).
Expression of fibrosis-related genes such as Col-1a, Col-3a,
and lysyl oxidase was reduced (Figure S5C), suggesting that
impaired glucose tolerance in H2AKO mice was not associated
with adipose tissue fibrosis. Taken together, these results
show that HIF-2a can attenuate HFD-induced inflammation,
glucose intolerance, and insulin resistance.1346 Cell 157, 1339–1352, June 5, 2014 ª2014 Elsevier Inc.The HAKO Phenotype Dominates in Double-HIF-1a and
-2a KO Mice
Because HIF-1a and HIF-2a can be interactive, we studied
double-DHAKOmice (Figure 7A). DHAKOmice exhibited normal
body weight on HFD (Figure 7B). These mice displayed
increased eWAT mass and adipocyte size with reduced adipose
tissue fibrosis upon HFD (Figures 7C and 7D). Glucose tolerance
was normal on NCD, whereas on HFD, glucose and insulin
tolerance were significantly improved with lower insulin levels
(Figures 7E to 7H). Hyperinsulinemic euglycemic clamp studies
revealed increased GIR, IS-GDR, and greater suppression of
HGP and FFA levels in the DHAKO mice, indicating improved
systemic insulin sensitivity in muscle, liver, and adipose tissue
(Figure 7I). Alongwith thesemetabolic changes, the HFD-depen-
dent increase in ATM accumulation andM1-like polarization was
significantly reduced in the DHAKO mice (Figure 7J). Nitrite
accumulation in adipose tissue was also decreased in the
DHAKOmice (Figure 7K). Thus, although adipocyteHIF-2a dele-
tion leads to greater inflammation, glucose intolerance, and insu-
lin resistance, the double KOs completely phenocopy the results
with the HAKO mice. This indicates that loss of both isoforms
mirrors the results seen with loss of HIF-1a, indicating that the
main effect of HIF-2a is to counteract HIF-1a.
DISCUSSION
It is now well established that adipose tissue inflammation is an
important component of the obese state and that this inflamma-
tory response is a major contributor to the systemic insulin resis-
tance that characterizes obesity and type 2 diabetes (Glass and
Olefsky, 2012). However, the early events that initiate this inflam-
matory response are less well understood and are obviously
central to defining the etiology of the insulin-resistant, inflamma-
tory state. Our data demonstrate that HIF-1amRNA and protein
levels are highly induced early in the course of HFD-induced
obesity, well before significant adiposity develops. Obviously,
HIF-1a induction occurs when cells sense hypoxia, and our
data show that SFA stimulation of ANT2 causes increased
adipocyte oxygen consumption due to uncoupled mitochondrial
respiration, leading to a state of relative cellular hypoxia; this
triggers HIF-1a expression and induces adipocyte chemokine
production with increased ATM content and tissue inflammation.
This results in glucose intolerance and insulin resistance (Fig-
ure S5D), all of which are mitigated by adipocyte HIF-1a deletion
or ANT2 inhibition. With this scenario, adipocyte hypoxia and
induction of HIF-1a function as early triggers for inflammation
and insulin resistance.
It is commonly assumed that, in obese adipose tissue,
enlarging adipocytes outstrip the perfused blood oxygen supply,
resulting in areas of microhypoxia. Although decreased adipose
tissue oxygen tension exists in obese adipose tissue (Pasarica
et al., 2009), the hypoxia literature suggests that, in nonischemic
tissue, increased cellular oxygen consumption is often themajor,
or at least an important, contributing factor to relative cellular
hypoxia (Hagen et al., 2003). Indeed, our current studies demon-
strated that oxygen consumption is markedly elevated in eWAT
adipocytes obtained from HFD/obese mice compared to lean
mice. This leads to a state of relative adipocyte hypoxia with
Figure 6. H2AKO Impairs Glucose and Insulin Tolerance with Increased Adipose Tissue Inflammation
(A) mRNA levels of HIF-1a and HIF-2a in adipose tissue of HFD WT or H2AKO mice. n = 6.
(B) Body weight of WT and H2AKO mice fed NCD (n = 10) or HFD (n = 36).
(C) eWAT mass on NCD and HFD (15 weeks; n = 5 per group).
(D) GTT in NCD mice.
(E) GTT performed in 10 week HFD mice.
(F) Plasma insulin level during GTT in (E).
(G) ITT test with mice on 11 week HFD.
(H) Flow cytometry analysis of eWAT SVCs. n = 4 or 9 per group.
(I) RT-PCR analysis of inflammatory gene expression in primary adipocytes from HFD WT or HFD H2AKO mice. n = 6 per group.
All data represent mean ± SEM. See also Figure S5.HIF-1a induction and proinflamamtory signaling. All of these
effects were seen after as early as 1 and 3 days of HFD.
Furthermore, our results indicate that the mechanism for this
uncoupled respiration relates to the elevated FFA levels
commonly seen in obesity. In the context of HFD and obesity,
there are several ways in which increased fatty acid availability
could occur. First, increased adipocyte lipolysis, particularly in
visceral fat, is a well-known early characteristic of the obese
state (Nielsen et al., 2004), and, as a later event, adipocyte
insulin resistance leads to decreased antilipolytic effects of in-
sulin, which would further increase these local fatty acid levels.
The intracellular concentration of FFAs is likely to be even
higher in adipocytes because up to 50% of FAs hydrolyzed
from the TG droplet can be directed toward re-esterification
(Leibel et al., 1985). Finally, HFD leads to an increased systemic
fat load due to incoming chylomicrons, which are subsequentlyhydrolyzed at tissue sites, giving rise to increased tissue fatty
acid exposure. Although the proportional contribution of each
of these components to overall FA exposure needs to be deter-
mined, our data directly show a 2- to 4-fold elevation in adipose
tissue FFA levels as early as 3 days on HFD. We found strong
evidence that SFAs can cause uncoupled adipocyte respiration
by demonstrating that SFA treatment of 3T3-L1 adipocytes
directly leads to increased oxygen consumption by activation
of ANT2. This mechanism translated to the in vivo situation
because depletion of epididymal adipose tissue ANT2 led to
decreased adipose hypoxia in HFD mice. In addition, treatment
of obese mice with the ANT inhibitor, CAtr, greatly reduced the
number of hypoxic adipocytes. In vivo CAtr administration also
led to decreased adipose tissue inflammation and, most impor-
tantly, improved glucose tolerance with increased insulin sensi-
tivity. Taken together, our results support the idea that SFAsCell 157, 1339–1352, June 5, 2014 ª2014 Elsevier Inc. 1347
Figure 7. DHAKO Mice Exhibit Similar Metabolic Changes to HAKO Mice
(A) mRNA levels of HIF-1a and HIF-2a in adipose tissue of HFD WT or DHAKO mice.
(B) Body weight (BW) of WT and DHAKO mice on HFD. n = 18 or 20 per group.
(C) eWAT mass on NCD and HFD (15 weeks). n = 7 or 10 per group. *p < 0.05.
(D) Trichrome (blue) and H&E stainings of eWAT from mice fed a HFD for 15 weeks.
(E and F) GTT in mice fed a NCD (E) or HFD for 10 weeks (F). *p < 0.05.
(G) Plasma insulin level during GTT in (F).
(H) ITT in mice fed a HFD for 11 weeks. *p < 0.05; ***p < 0.001.
(I) Hyperinsulinemic euglycemic clamp with mice fed a HFD for 15 weeks. *p < 0.05.
(J) Flow cytometry analysis of eWAT SVCs. n = 7 or 10 per group. *p < 0.05. (K) Nitrite level in eWAT of WT and DHAKOmice on chow or HFD. n = 4 or 5 per group.
*p < 0.05.
All data represent mean ± SEM.increase oxygen consumption by facilitating ANT2-mediated
uncoupled respiration and that this is a key contributor to rela-
tive cellular hypoxia in obesity triggering the HIF-1a response.
This is likely to be a major mechanism for adipose tissue hyp-
oxia because one would not expect decreased oxygen perfu-
sion after 1 day of HFD, when adipose tissue expansion and
remodeling have not yet occurred.
In our KO mouse studies, genetic deletion of HIF-1a from ad-
ipocytes is sufficient to cause systemic insulin sensitivity in liver
andmuscle. This emphasizes the degree towhich adipose tissue
can communicate to other key insulin target tissues and indi-1348 Cell 157, 1339–1352, June 5, 2014 ª2014 Elsevier Inc.cates the primacy of changes in adipose tissue in the context
of systemic insulin action. It is also important to note that, with
adipocyte HIF-1a deletion, not only did inflammation decrease
in adipose tissue, but it also was markedly reduced in liver.
This indicates another potential way in which adipose tissue
can signal to other tissues because it is likely that the decreased
hepatic inflammation is secondary to the primary changes in
adipose tissue.
We found that the ratio of iNOS to arginase was increased in
HFD adipose tissue and primary adipocytes, leading to
increased generation of NO. Previous reports have shown that
NO can result in decreased cellular insulin sensitivity by causing
inhibitory nitrosylation of Akt (Yasukawa et al., 2005) and that
iNOS KO mice are protected from HFD-induced insulin resis-
tance (Perreault and Marette, 2001). Consistent with this, we
found that nitrosylation of Akt is increased in HFD adipose tissue
and that this is associated with decreased insulin-stimulated Akt
phosphorylation. We also show a decreased adipose tissue
iNOS/arginase ratio in the HAKO mice, resulting in less NO
production with decreased Akt nitrosylation and improved
insulin-stimulated Akt phosphorylation. This suggests that
inflammation-mediated increased tissue NO production, with
Akt nitrosylation, is a cytokine-independent mechanism for
obesity-induced insulin resistance and that attenuation of this
NO effect is a component of the enhanced insulin sensitivity
observed in the HAKO mice.
In contrast to the beneficial effects of HIF-1a KO, deletion of
adipocyte HIF-2a led to increased inflammation and exacerba-
tion of insulin resistance on HFD. This suggests that HIF-2a
normally plays a protective role from obesity-induced
decreased insulin sensitivity. Interestingly, in the DHAKO
mice, the HIF-1a deletion was dominant because the pheno-
type of DHAKO and HAKO mice was comparable. One possible
explanation for these results is that HIF-1a actively promotes
inflammation and impairs insulin sensitivity on HFD, whereas
the protective effects of HIF-2a are accomplished by counter-
acting HIF-1a.
Previous reports on HIF-1a KO or transgenic mice are
consistent with our results with respect to the overall metabolic
phenotype. For example, ARNT is the heterodimeric binding
partner for both HIF-1a and HIF-2a, and Jiang et al. (2011)
and Lee et al. (2011a) reported that adipocyte-specific deletion
of ARNT led to protection from HFD-induced obesity, glucose
intolerance, and insulin resistance. In the paper by Jiang et al.
(2011), this was accompanied by decreased adipose tissue
inflammation. These studies also show protection from HFD-
induced weight gain, which was not a feature of our HAKO
mice. This is probably due to the fact that ARNT deletion has
broader effects beyond HIF-1a inhibition because it would
also lead to decreased HIF-2a activity, as well as decreased
activity of another ARNT binding partner, AhR. On the other
hand, Zhang et al. (2010) found that transgenic expression of
a dominant-negative HIF-1a construct in adipose tissue led
to obesity and decreased energy expenditure in mice, leaving
the relationship between HIF-1a, energy expenditure, and
weight gain unresolved. Finally, Sun et al. (2013) show that
treatment of mice with a small-molecule HIF-1a inhibitor, as
well as adipocyte transgenic expression of a dominant-nega-
tive HIF-1a, led to protection from HFD-induced glucose intol-
erance, insulin resistance, adipose tissue inflammation, and
obesity. In the current studies (Figures S3A and S5A), as well
as in past publications (Barak et al., 2002; He et al., 2003; Li
et al., 2011), we have shown that aP2-cre expression is highly
specific for adipocytes in our aP2 mouse model. Thus, we have
found no cre-mediated target gene recombination in muscle,
liver, SVCs, or IP macrophages (Figures S3A and S5A).
Although the majority of studies from other laboratories agree
with this (Ahmadian et al., 2011; Chalkiadaki and Guarente,
2012; Polak et al., 2008; Rohm et al., 2013; Sabio et al.,2008), there are a couple of reports showing variable degrees
of target gene recombination in macrophages with these aP2
mice (Garcia-Arcos et al., 2013; Paschos et al., 2012). Although
our current data in the HAKO and H2AKO mice clearly reveal
no evidence for HIF-1a or -2a deletion in macrophages, it is
always possible that some degree of recombination might
have gone undetected. Although some of the detailed findings
differ among the various studies, when taken together with the
current results, it is clear that HIF-1a deletion from adipocytes
has beneficial metabolic effects to mitigate HFD-induced
adipose tissue inflammation, glucose intolerance, and insulin
resistance.
The current studies reveal an important role for HIF-1a as
an early event that can trigger the adipose tissue inflamma-
tory response, leading to systemic insulin resistance. At the
onset of HFD, we find that increased adipocyte oxygen con-
sumption due to uncoupled oxidative metabolism is a major
contributor to a state of relative adipocyte hypoxia, providing
the stimulus for adipocyte HIF-1a induction. In turn, we have
traced the mechanism of uncoupled respiration to the effects
of SFAs to stimulate ANT2 activity, which is known to disrupt
the mitochondrial membrane proton gradient leading to
uncoupled respiration. This leads to the sequential hypothesis
(Figure S5D) that elevated FFA levels in obesity provide an
early activating event leading to ANT stimulation, uncoupled
respiration, with increased oxygen consumption inducing a
state of relative adipocyte hypoxia. This then triggers the
HIF-1a response. In the chronic long-term obese setting,
the hypoxia is likely exaggerated by an additional component
of decreased oxygen perfusion. In turn, HIF-1a stimulates
production of the key adipocyte-derived chemokines MCP-1
and LTB4, which drive accumulation of proinflammatory
ATMs. This leads to a state of adipose tissue inflammation
with the subsequent deleterious effects on systemic insulin
sensitivity. Once proinflammatory macrophages appear in
adipose tissue, they release their own chemokines, setting
off a second wave of chemotaxis and ATM accumulation.
This then exacerbates the inflammatory/insulin resistance
state. In this sequential hypothesis, fatty acid stimulation of
ANTs would be an initiating event. The current studies identify
early events in the inflammation/insulin resistance syndrome
that provide an improved understanding of these pathophys-
iologic processes and could lead to new opportunities for
therapeutic intervention.
EXPERIMENTAL PROCEDURES
Animals and Treatments
To induce adipocyte-specific genetic ablation, mice with homozygous loxP re-
combinase recognition site-flanked HIF-1a and/or HIF-2a alleles were bred to
mice expressing Cre recombinase driven by aP2 promoter (Li et al., 2011).
Mice were housed in colony cages in 12 hr light/12 hr dark cycles. For HFD
study, mice were subjected to 60% HFD for the indicated time periods
(Research Diets, USA). OGTTs and ITTs were performed as described previ-
ously (Lee et al., 2013). Mouse clamp experiments were performed as
described previously (Lee et al., 2011b). During the clamps, insulin was infused
at a constant rate of 8.0 mU/kg/min. All animal procedures were in accordance
with the research guidelines for the use of laboratory animals of University of
California, San Diego. Detailed protocols are described in the Extended
Experimental Procedures.Cell 157, 1339–1352, June 5, 2014 ª2014 Elsevier Inc. 1349
Measurement of Oxygen Consumption
Relative oxygen consumption rate of adipocytes was measured polarograph-
ically using Clarke-type electrode (Oxytherm, Hansatech). For oxygen
measurements, primary adipocytes were prepared from epididymal adipose
tissues from chow or HFD mice with collagenase digestion, or fully differenti-
ated 3T3-L1 adipocytes were detached from plates. Cells were washed with
PBS three times and resuspended into HEPES-buffered serum-free DMEM
and incubated in the Clarke type electrode chamber maintained at 37C and
continuously stirred. After measurement of oxygen consumption rate, each
of the cell suspensions was save for total lysate preparation to assess total
protein content. Oxygen consumption rate was calculated by normalizing
oxygen consumption rate (nmole/s) to total protein content (mgs). The effect
of FFAs on increasing oxygen consumption in 3T3-L1 adipocytes was
confirmed by oxygen measurements using Seahorse XFe96 Analyzer
(Seahorse Bioscience).
ANT Knockdown
To KD ANT1 or ANT2 in 3T3-L1 adipocytes, duplex siRNAs against mouse
ANT1 or ANT2 purchased from Integrated DNA Technology were intro-
duced into 5 day differentiated 3T3-L1 adipocytes using electroporation.
For in vivo knockdown of ANT2 in adipose tissue, mice were anesthetized
and subjected to laparotomy and were given five injections of 2 ml (2 3
1013 gc/ml) of AAV solution into each epididymal fat pad using a Hamilton
syringe. Detailed protocols are described in the Extended Experimental
Procedures.
Glucose Uptake Assays
Glucose uptake in primary adipocytes was measured as described previously
(Lee et al., 2008).
Flow Cytometry
Flow cytometry analysis of adipose tissue macrophages was performed as
described previously (Lee et al., 2011b).
Nitrate and Protein Nitrosylation Measurement
Nitrate content in epididymal adipose tissue lysate wasmeasured usingGriess
Reagent System (Promega) in accordance with the manufacturer’s protocol.
Detailed protocols for protein nitrosylation measurement are described in
the Extended Experimental Procedures.
Lactate Measurement
Lactate content in total adipose tissue lysate was measured by colorimetric
lactate assay kit (Biovision, USA).
Macrophage Migration Assays
In vitro migration of macrophages was measured as described previously (Lee
et al., 2011b). For preparation of ACM, primary adipocytes from HFD WT or
HFD HAKO were incubated in Dulbecco’s modified Eagle’s media supple-
mented with 0.2% BSA for 12 hr. In vivo macrophage tracking experiments
was performed as described previously (Oh et al., 2012). Detailed protocols
are described in the Extended Experimental Procedures.
Histology
Immunohistochemistry analyses were performed as described previously (Lee
et al., 2010, 2011b). For hypoxia staining, NCD or HFD mice were i.p. injected
with pimonidazole hydrochloride (60 mg/kg) and/or CAtr (2 mg/kg) 1 hr before
sacrifice. The mice were anesthetized by an intramuscular injection of a
combination of anesthetics, and their adipose tissues were whole mounted
after fixation by vascular perfusion of 1% paraformaldehyde in PBS. Adipose
tissue was stained with FITC-conjugated antibodies against pimonidazol
adducts (HPI), which form in hypoxic tissue, and was visualized using confocal
fluorescence microscopy. For measurement of macrophage or collagen fiber
accumulation in adipose tissue, paraffin-embedded tissue sections were
stained with anti-F4/80 antibody (Serotech; cat. MCA497B) or trichrome,
respectively. Microscopic images were analyzed using ImageJ software.1350 Cell 157, 1339–1352, June 5, 2014 ª2014 Elsevier Inc.Adipose Tissue FFA measurement
FFA concentration in adipose tissue wasmeasured by Lipomics (CA). Detailed
protocols are described in the Extended Experimental Procedures.
Statistics
The results are shown asmeans ±SEM. All statistical analyseswere performed
by Student’s t test; p < 0.05 was considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cell.2014.05.012.
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